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Available online 12 August 2016Commercialization of nanotechnologies entails a regulatory requirement for understanding their environmental,
health and safety (EHS) risks. Today we face challenges to assess these risks, which emerge from uncertainties
around the interactions of manufactured nanomaterials (MNs) with humans and the environment. In order to
reduce these uncertainties, it is necessary to generate sound scientiﬁc data on hazard and exposure by means
of relevant frameworks and tools. The development of such approaches to facilitate the risk assessment (RA)
of MNs has become a dynamic area of research. The aim of this paper was to review and critically analyse
these approaches against a set of relevant criteria. The analysis concluded that none of the reviewed frameworks
were able to fulﬁll all evaluation criteria.Many of the existingmodelling tools are designed to provide screening-
level assessments rather than to support regulatory RA and risk management. Nevertheless, there is a tendency
towards developing more quantitative, higher-tier models, capable of incorporating uncertainty into their anal-
yses. There is also a trend towards developing validated experimental protocols for material identiﬁcation and
hazard testing, reproducible across laboratories. These tools could enable a shift from a costly case-by-case RA
ofMNs towards a targeted, ﬂexible and efﬁcient process, based on grouping and read-across strategies and com-
pliantwith the 3R (Replacement, Reduction, Reﬁnement) principles. In order to facilitate this process, it is impor-
tant to transform the current efforts on developing databases and computational models into creating an
integrated data and tools infrastructure to support the risk assessment and management of MNs.
© 2016 Elsevier Ltd. All rights reserved.Keywords:
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11. Introduction
Nanotechnology is one of the key emerging technologies identiﬁed
in the European Union (EU) 2020 Strategy (European Commission,
2010). It has enormous potential to contribute to innovation and eco-
nomic growth, which has fostered large investments in developing
new industrial applications. However, current uncertainties around
the Environmental, Health and Safety (EHS) risks of manufactured
nanomaterials (MNs) have raised societal concerns about the adequa-
cy of their regulation (Hristozov et al., 2012). In order to protect
nanotechnology innovation sound scientiﬁc analysis of the MNs
implications is required, taking into consideration all stages of their
lifecycles.
The paradigm for Risk Assessment (RA) of chemicals is considered
applicable toMNs if properly adapted to address the complexity associ-
ated with their identity, biological and environmental interactions
(OECD and European Commission, 2012, EFSA, 2010, Stone et al.,
2013). RA systematically applies scientiﬁc principles to estimate the
probability that adverse human health or environmental effects could
emerge from exposure to chemicals. The RA framework is composed
of problem formulation, exposure assessment, hazard assessment, and
risk characterization (Van Leeuwen and Vermeire, 2007). Speciﬁcally,
the problem formulation is a systematic planning activity that sets the
goals and the scope of the RA. The exposure assessment formulates ex-
posure scenarios describing how a chemical is used by workers or con-
sumers or how it is released into the environment. This is followed by
estimations of exposure for one ormore routes (i.e. inhalation, ingestion
or dermal) or environmental compartments (e.g. water, sediment, soil)
under the conditions of use described in the exposure scenarios. This
may involve monitoring of indoor or outdoor concentrations by means
of suitable analytical instruments and/or the estimation of the amount
of the substance reaching humans or target environmental species by
means of models. The hazard assessment involves the analysis of avail-
able data on (eco)toxicological effects in order to establish dose-re-
sponse relationships. The risk characterization combines hazard and
exposure to estimate risk.
There is a considerable volume of research and regulatory activity in
the nanoEHS area, pointing to the fact that the (eco)toxicology and ex-
posure data obtained for larger particles or for chemicals are generally
useful and relevant to the evaluation of MNs hazards and risks
(Donaldson and Poland, 2013). Nevertheless, the feasibility study of
performing RA for MNs has identiﬁed serious gaps in our basic under-
standing of key nano-bio interactions, mechanisms of biological uptake,
fate, distribution and bioaccumulation that have led to ambiguous,
largely qualitative risk estimations based on expert judgments, which
may fail to support proper risk management decision making
(Hristozov et al., 2012). In order to ﬁll the gaps, the academic communi-
ty has been working together with industries and regulators for more
than 10 years to develop frameworks and tools for RA of MNs. RA strat-
egies have been reviewed in the past (Hristozov et al., 2012, Grieger et
al., 2012, Som et al., 2013, Olson and Gurian, 2012) but the ﬁeld of
nanoEHS has rapidly developed and signiﬁcant advancements have
been made, which requires an update of these reviews.
In an attempt to avoid confusion in using the terms “framework”,
and “tool”, we provide provisional deﬁnitions of them in the context
of RA. A “framework” is a conceptual paradigm of how RA should beunderstood and performed. An example is the Chemical Safety Assess-
ment (CSA) required by theREACH(Registration, Evaluation, Authorisa-
tion and Restriction) regulation. “Tools” are implements used to carry
out particular functions or accomplish speciﬁc tasks (e.g. estimate expo-
sure, build a dose-response curve). They can be for example speciﬁc
models, experimental protocols or databases.
The main aim of this review paper is to analyse and evaluate the
available frameworks and tools for RA of MNs against relevant
criteria and discuss their strengths and weaknesses. This analysis
had a strong focus on ongoing advancements in EU and U.S. research
projects.
2. Methodology
2.1. Critical review of peer-reviewed literature
Published literature from 2000 to 2015 was searched for studies
on RA of MNs by querying the Web of Science database with 10
keywords (nano, risk assessment, framework, methodology, meth-
od, tool, protocol, database, library, inventory). The search [string
ts = (nano* and (risk assessment) and (framework or methodology
or method or tool or protocol) and (database or library or invento-
ry)] retrieved 1749 records, out of which 46 papers described 6
frameworks and 14 tools relevant for the RA of MNs. In addition,
the regulatory frameworks within the EU were considered. In
order to critically review the identiﬁed approaches against a set of
criteria, the relevant papers were divided into two categories: i) re-
view or opinion papers; and ii) research papers that described spe-
ciﬁc frameworks or tools. Our critical appraisal focused on the
second type of papers as they represent primary sources of infor-
mation, while the opinion and review papers were only used to
identify evaluation criteria and research trends.
2.2. Critical review of grey literature and information collected through a
survey
The analysis of peer-reviewed literaturewas complemented by a re-
view of results from relevant research projects. In order to identify
those, we performed a search on CORDIS with the same keywords.
This revealed a number of EU-funded projects, which are reported in
the European Nanosafety Cluster Compendium. The scientiﬁc ﬁndings
from these projects were assessed through a review of their interim re-
ports and deliverables that were publically available or accessible to the
authors. The identiﬁed frameworks and tools were evaluated against
the criteria reported in Table 1.
In addition, a “google docs” online questionnaire was developed to
survey organisations that are involved in developing nanoEHS tools. Po-
tential participants and their contact information were identiﬁed from
the European NanoSafety Cluster Compendium and personal communi-
cations with relevant individuals. The questionnaire (cf. Supplemental
Information) covered several aspects characterising a tool: Scope, appli-
cation domain, regulatory relevance, input data requirements, analytical
methodology, expected outputs/results, case studies used for demon-
stration, stakeholders' involvement, and future research directions. It
was distributed to representatives of the identiﬁed EU projects through
the channels of the NanoSafety Cluster as well as to key centres in the
Table 1
Frameworks and tools evaluation criteria.
Frameworks
Criterion Justiﬁcation Selected references
Nano-speciﬁc requirements MNs present new physicochemical properties that may inﬂuence their kinetics,
bioavailability, toxicity and fate. Thus, these nano-speciﬁc parameters need to be
investigated during the exposure assessment and hazard assessment steps in order
to increase the level of certainty in the RA results (Stone et al., 2014).
Environmental Defense and DuPont (2007), Pronk
et al. (2009), Bos et al. (2015), ECHA, JRC and RIVM
(2016)
Lifecycle thinking It is important to assess the risks of MNs from a lifecycle perspective since the
characteristics of some MNs are likely to change signiﬁcantly during their lifetime,
which would affect their hazard, exposure and risk.
RENN and ROCO (2006), Shatkin (2008), SCENIHR
(2007), SCENIHR (2009), Bos et al. (2015), ECHA,
JRC and RIVM (2016), SCCS (2012)
Pre-assessment phase Case-by-case RA of MNs can be very resource intensive. In order to focus the
assessment and avoid unnecessary testing costs, careful objective prioritization
and planning are needed, which should take place in the fundamental problem
formulation step.
RENN and ROCO (2006), Shatkin (2008), Grieger et
al. (2012), Hristozov et al. (2012), Stone et al.
(2014), Bos et al. (2015)
Exposure-driven approach It has been recognized that the testing of the currently available and still emerging
MNs in all their formulations is cost-prohibitive. This is why careful prioritization
of MNs is required to optimize testing efforts. We argue that it may be more
appropriate to conduct this prioritization following an exposure-driven approach.
This would allow us to exclude irrelevant exposure routes, leading to likely
waiving of the testing associated with them. In addition, it can support
prioritization of exposure scenarios in order to ﬁrst focus on the most relevant
ones; if the exposure is negligible then the hazard data may be waived.
SCCS (2012), Stone et al. (2014), Bos et al. (2015)
Iterative and adaptive structure In the next years more empirical data will appear for RA of MNs. Thus, there is
need for iterative and adaptive frameworks, allowing the rapid inclusion of new
information in the decision analytical process as it becomes available.
RENN and ROCO (2006), SCENIHR (2007), SCENIHR
(2009), Stone et al. (2014), Bos et al. (2015)
Transparency of objectives and
communication with all involved
stakeholders
It is important to consider the socio-economic, cultural and political context of the
RA process and dialogue with all relevant stakeholders involved in it.
RENN and ROCO (2006), Hristozov et al. (2012),
Stone et al. (2014), Bos et al. (2015)
Documented applications Documented applications are the best way to test a framework, conﬁrm its
functionality and understand its strengths and limitations.
Grieger et al. (2012), Hristozov et al. (2012), Bos et
al. (2015)
Allowing for/giving directions on
grouping and read-across of MNs
Grouping and read-across of MNs can help to make optimal use of the available
data for RA.
(Oomen et al., 2015)
Tools
Easy to use Tools that are easy to use do not require speciﬁc expertise for their application.
They are particularly relevant for Small and Medium Enterprises (SME) as those
companies often do not have staff with experience suited to apply sophisticated
protocols or models.
Hristozov et al. (2012), Subramanian et al. (2015)
Quantitative information Tools that require quantitative input information to function cannot be easily
applied in data-poor situations, which reduces their overall applicability.
Grieger et al. (2012), Hristozov et al. (2012), Bos et
al. (2015), Subramanian et al. (2015)
Uncertainty analysis Clearly communicating the uncertainty and variability in modelling results
through sound uncertainty analysis greatly helps decision making. It could be
otherwise easily misled by overconﬁdent communication of uncertain RA results.
Hristozov et al. (2012), Stone et al. (2014),
Hristozov et al. (2016)
Assessment tier The assessment tier criterion distinguishes the “screening-level” from the
“high-tier” tools.
Stone et al. (2014), Bos et al. (2015)
Lifecycle thinking It is important to assess the risks of MNs from a lifecycle perspective since the
characteristics of some MNs are likely to change signiﬁcantly during their lifetime,
which would affect their hazard, exposure and risk.
Stone et al. (2014), Bos et al. (2015)
Documented applications Documented applications are the best way to test a tool, conﬁrm its functionality
and understand its strengths and limitations.
Grieger et al. (2012), Hristozov et al. (2012), Bos et
al. (2015)
Transparency of application To make it easy it is for stakeholders to quickly comprehend how speciﬁc data
points and decision criteria inﬂuence decision making.
Subramanian et al. (2015)
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plicitly asked to ﬁll in the questionnaire for one tool at the time. The re-
sults obtained from 29 organisations are presented in Table 4.
The analysis of “grey” documents from the research projects and the
results of the survey identiﬁed 32 (sets of) tools, different from the ones
derived from the peer-reviewed literature. This is not a discrepancy, but
a difference caused by the fact that these tools are currently being devel-
oped and have not been published.
2.3. Evaluation criteria
The frameworks and tools identiﬁed from the review of literature
and the information collected through the survey were evaluated
against the criteria reported in Table 1. It is important to note that not
all criteria ﬁt to each tool and they cannot serve as a means for compar-
ison as the tools have different goals in the overall RA approach, and
they were developed in response to the needs of different stakeholders.
Instead, these categories are to be used on a general information level toindicate some of the factors that the stakeholders should considerwhen
seeking to perform RA of MNs. Therefore, we judge none of the frame-
works or tools as superior or inferior to the others based on the evalua-
tion criteria.
These criteria were derived from the state of the art literature, in-
cluding the results of the major EU projects ITS-Nano and MARINA,
which collectively involved the majority of European experts on RA of
MNs from academia, industry and regulation to discuss such criteria in
the context of developing intelligent testing and RA strategies for MNs
(Stone et al., 2014, Bos et al., 2015, Oomen et al., 2014a). Some of
these criteria consider methodological characteristics, such as
“nanospeciﬁcity”, “exposure-driven approach”, “iterative and adaptive
structure”, “lifecycle thinking”, “allowing for/giving directions on
grouping and read-across”, “uncertainty analysis”. Others address the
applicability of the approaches: e.g. “easy to use”, “quantitative infor-
mation”, “documented applications”, “transparency of application”,
and “assessment tier”. Тhe selection of each criterion is justiﬁed in
Table 1.
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3.1. Frameworks for RA of MNs
Several frameworks of relevance for the RA of MNs have been pro-
posed by regulatory bodies, non-governmental organisations, industry,
and the scientiﬁc community. Table 2 lists their strengths and limita-
tions from scientiﬁc perspective, while Table 3 evaluates them against
the criteria listed in Table 1.
The frameworks are all based on the RA paradigm for chemicals and
recommend a number of adaptations to address the complexity associ-
ated withMNs. Most of them stress the importance of the Problem For-
mulation as an essential prerequisite to the planning of the RA process
in order to avoid unnecessary testing. Most of the frameworks allow
for considering exposure aspects at the initial stage of the RA to inform
(eco)toxicological investigations (Shatkin, 2008, RENN and ROCO, 2006,
SCENIHR, 2007, 2009). This exposure-driven approach can potentially
exclude irrelevant exposure routes, thus waiving unnecessary hazard
testing in compliance with the 3Rs (Replacement, Reduction, Reﬁne-
ment) principles. In addition, it can insure that information gathering
is optimised to address themost relevant exposure scenarios. Thewaiv-
ing of testing is in principle allowed under REACH (Annex XI) for any
substance if the registrant can demonstrate absence of exposure or no
signiﬁcant exposure for all scenarios. In the European Food Safety Agen-
cy (EFSA) and Scientiﬁc Committee on Consumer Safety (SCCS) frame-
works, it is more explicitly recommended that exposure
considerations are anticipated to reduce testing for cases where the ab-
sence of exposure to MNs can be veriﬁed through demonstration of e.g.
no migration of MNs into food/feed matrix from packaging, complete
dissolution/degradation of theMNs in the food/feedmatrix, or no trans-
location of theMNs across the skin. Despite the clear beneﬁts of this ap-
proach, there are signiﬁcant technical limitations to its application,
which include challenges in detection and quantiﬁcation of MNs in
complex environmental and food matrices and the lack of validated ex-
posure modelling tools (SCCS, 2012).
The data requirements of most frameworks are similar to the ones
set in the “Guidance on Information Requirements and Chemical Safety
Assessment” under REACHprovided by the EuropeanChemicals Agency
(ECHA) and emphasize the need for comprehensive characterization of
physicochemical properties (Pronk et al., 2009, SCENIHR, 2007,
Environmental Defense and DuPont, 2007). Usually, the suggested
properties to be determined include those listed by the OECD Working
Party on Manufactured Nanomaterials (WPMN) (OECD, 2010). Speciﬁ-
cally, SCENIHR recommend that adequate physicochemical characteri-
zation of MNs should study their transformations in different lifecycle
stages, which requires investigation of different forms of the materials
in different media (SCENIHR, 2007). More speciﬁcally, EFSA recom-
mended that the physicochemical characterization of MNs is performed
at ﬁve stages of the lifecycle: i) as manufactured (pristine), ii) as deliv-
ered for use in food/feed products, iii) as present in the food/feed ma-
trix, iv) as used in toxicity testing, and v) as present in biological ﬂuids
and tissues. Similarly, SCCS recommends that physicochemical charac-
terization of MNs is performed at three stages: i) as manufactured, ii)
after addition to a cosmetic formulation, and iii) during toxicological in-
vestigations (SCCS, 2012).
The importance of thorough physicochemical characterization is
also stressed by the ongoing efforts to establish criteria for grouping
and read-across of MNs in order to reduce animal testing. This has be-
come a dynamic area of research and several frameworks for grouping
and read-across of MNs have been proposed (Arts et al., 2015a, RIVM,
2015, ECHA, JRC and RIVM, 2016, Gebel et al., 2014, Walser and
Studer, 2015). These approaches are still rather conceptual and are not
based on sufﬁcient understanding of the interdependencies among the
intrinsic and extrinsic properties of MNs and their observed adverse bi-
ological effects (Oomen et al., 2015). They were developed from either
human health (Arts et al., 2015a) or environmental (RIVM, 2015)perspective and therefore differ signiﬁcantly in the hierarchy of investi-
gated physicochemical properties. Schemes developed from an occupa-
tional perspective often use “morphology” as a key grouping criterion,
which was motivated by the well-established concern of inhalation of
ﬁbrousmaterials. In contrast, schemes developed from an environmen-
tal perspective assign more importance on properties such as hydro-
phobicity and surface charge. Both perspectives regard the reactivity
and the shedding of heavy metal ions as important criteria.
3.2. Tools for RA of MNs
Forty eight tools to facilitate the RA of MNs were identiﬁed from the
published literature and from projects (Table 4). They are grouped into
types: Control banding, risk screening, occupational and consumer ex-
posure, environmental fate and exposure, hazard assessment, physico-
chemical characterization, and decision support tools. Table 4
evaluates each tool against the criteria listed in Table 1.
3.2.1. Control banding and risk screening tools
Control banding is a family of qualitative and semi-quantitative
models used to estimate hazard and exposure potentials of chemicals
in order to assess the levels of precaution required to control their
risks. Risk control is achieved through recommendation of appropriate
Risk Management Measures (RMM) such as engineering and adminis-
trative controls as well as Personal Protective Equipment (PPE) (Paik
et al., 2008). The hazard and exposure potentials are measured on nor-
malized scales called “bands”. These bands are typically plotted on a
two-dimensional matrix, which results in establishing a control band
associated to a speciﬁed level of precaution and a set of RMM to be
implemented.
The control banding tools are always linked to speciﬁc occupational
control measures and are developed and applied for workplace safety
only. Risk screening is a similar approach, but it is also applicable for
consumer and environmental RA.
3.2.1.1. Control banding tools. Control banding was proposed as an ap-
proach to implement the Precautionary Principle for risk management
decisionmaking in the cases when the available data and/or knowledge
were insufﬁcient for conducting regulatory RA ofMNs (Maynard, 2007).
Since then, several nano-speciﬁc control banding tools have been intro-
duced. These tools were discussed by Brouwer (2012), whose review is
updated in this paper. In regard to our evaluation criteria the control
banding tools are easy to use and require minimum input information,
which makes them suited for application by Small and Medium Enter-
prises (SMEs), which often do not have the resources and expertise to
use more sophisticated tools.
The majority of the nano-speciﬁc control banding tools are semi-
quantitative. One example is the model proposed by Paik et al. (2008),
which estimates “severity” of hazard and “probability” of exposure
scores and plots them in a matrix to obtain one out of four levels of
risk and associated RMM: Level 1: general ventilation; Level 2: fume
hoods or local exhaust ventilation; Level 3: containment; Level 4: seek
specialist advice. Similarly, the ANSES system is a semi-quantitative
tool estimating bands based on sequential sets of questions, ordered
in a decision tree (Ostiguy et al., 2010). The Stoffenmanager Nano com-
bines semi-quantitative hazard information with qualitative estimates
of inhalation exposure potential to assess risk (Duuren-Stuurman et
al., 2011), as the exposure considerations in the tool are informed by a
conceptual model described by Schneider et al. (2011).
In most cases the above tools consider nano-speciﬁc physicochemi-
cal characteristics in their estimations. In the ANSES system the hazard
banding uses a classiﬁcation scheme that is based on nano-relevant
properties such as solubility and reactivity. Size is not considered, but
aspect ratio is used to classify the bio-persistent ﬁbres always in the
highest hazard band. Stoffenmanager Nano distinguishes between sin-
gle particles and agglomerates/aggregates and sets the following
Table 2
Overview of the strengths and limitations of the available frameworks for RA of MNs.
Framework Structure Strengths Areas for improvement
Nanotechnology Risk
Governance (Renn and Roco,
2006)
The framework consists of ﬁve phases:
1. Pre-assessment (problem framing, early
warning and risk governance process
organization)
2. Risk appraisal (Risk and Concern
assessments)
3. Tolerability and acceptability judgement
4. Risk management
5. Risk communication
• Data sharing is encouraged
• Societal concerns and issues are taken into
account
• Risk communication is considered as an in-
tegral part of all stages of the risk gover-
nance process and crucial for the effective
linking the different components
• The framework speciﬁes neither which
properties should be investigated, nor
which endpoints should be tested
• Uncertainties are identiﬁed but no speciﬁc
action is planned to deal with them
Nano Risk Framework
(Environmental Defense and
DuPont, 2007)
The framework consists of six steps:
1. Describe material and application
2. Proﬁle lifecycle(s)
3. Evaluate risks
4. Assess Risk management
5. Decide, document and act
6. Review and adapt
• It considers the potential exposure
throughout the whole lifecycle of the MNs
• The framework is iterative and adaptive.
The RA is expected to be updated when
new information become available and re-
views have to be planned when performing
the ﬁrst RA.
• A template for reporting of the RA process
and communication of the risks is provided
(Output Worksheet)
• Although identiﬁed, uncertainties are han-
dled in a qualitative way: the framework
points out areas of uncertainty and data
gaps and suggests a ‘reasonable worst case’
approach.
• Some physicochemical properties relevant
for nano (e.g. dissolution, dustiness) recog-
nized as potential hazard descriptors are
not included in the base-set of required
information
SCENIHR (2007, 2009) The framework is a decision tree approach,
composed of four stages:
1. Assessment of need for exposure studies
2. Exposure characterization
3. Hazard identiﬁcation, characterization
4. Risk assessment
• A set of relevant physicochemical proper-
ties are identiﬁed and suggested as re-
quired information when performing the
RA
• The proposed approach is exposure-driven
and the need for in vivo tests must be jus-
tiﬁed by in vitro or in silico investigations,
which adds cost efﬁciency and is in accor-
dance with the 3R principle
• The framework does not provide any spe-
ciﬁc detail on exposure and hazard assess-
ment strategies
• Life cycle perspective, transparency and
adaption of the assessment are listed as
features of the framework. However, there
are no documented applications to demon-
strate these characteristics.
Nano-Life Cycle Risk Analysis
(Nano-LCRA) (Shatkin, 2008)
The framework consists of ten steps:
1. Description of the lifecycle of the
product
2. Identiﬁcation of the materials and as-
sess potential hazards in each lifecycle
stage
3. Qualitative exposure assessment for
materials at each lifecycle stage
4. Identiﬁcation of stages of lifecycle when
exposure may occur
5. Evaluation of the potential human and
non-human toxicity at key lifecycle
stages
6. Analysis of risk potential
7. Identiﬁcation of key uncertainties and
data gaps
8. Development of risk mitigation/-
management strategies
9. Gathering of additional information
10. Reiteration of the process.
• Nano LCRA is a screening-level framework
that can be applied when little information
is available
• “Mini” hazard and exposure assessments
are conducted for each step of the lifecycle
and further investigation (effects assess-
ment) is performed only for the steps
where exposure occurs, allowing saving
time and resources
• There is a step of the framework focused on
the evaluation of the level of conﬁdence in
the assessment. However, although key
sources of uncertainty are identiﬁed, the
framework does not suggest any speciﬁc
approach for their management
• This framework does not give any indica-
tion about the speciﬁc endpoints to be in-
vestigated
• Although the risk management is deﬁned
by the author as adaptive and transparent,
there is no documented application to
demonstrate this nature of the framework
Nanomaterials under REACH
(Pronk et al., 2009)
The framework represents a revision of the
approach for RA of chemicals applied under
REACH
• A “base-set” of nano-speciﬁc information is
required in the ﬁrst phase of the process
• The nature of the conventional RA ap-
proach ensures the inclusion of the princi-
ples of transparency and precaution in the
decision making process
• Exposure is considered throughout the
whole like cycle of the MNs
• The framework underlines all the signiﬁ-
cant uncertainties related to the RA of
nanomaterials, but a comprehensive strat-
egy to reduce and/or manage these uncer-
tainties is not proposed
Comprehensive Environmental
Assessment (CEA) (Davis et al.,
2010)
Consists of 5 steps:
1. Life cycle stages
2. Environmental pathways, i.e. identiﬁca-
tion of the media where the nanoparti-
cles can spread
3. Transport and transformation
4. Exposure via inhalation, ingestion or
dermal absorption
5. Effects (health and ecological)
• It considers the RA of a nanomaterial from a
lifecycle perspective
• It takes into account the variability of the
properties of nanomaterials by considering
the formation of manufacturing process
by-products and environmental transfor-
mation products
• Indications on some (but not all) properties
relevant for the characterization of
nanomaterials are provided
• It does not provide any speciﬁc procedure
to deal with uncertainties
• Although adaptability and transparency are
indicated as milestones of the framework,
these characteristics are not demonstrated
in any documented application
MARINA Framework (Bos et al.,
2015)
The framework is composed of two
subsequent phases and four pillars which
are closely linked. The two phases include:
• Nano-speciﬁc requirements
• Life cycle thinking
• Pre-assessment phase
• Exposure driven approach
• Still conceptual
• Has not been tested in real case studies yet.
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Table 2 (continued)
Framework Structure Strengths Areas for improvement
1. Problem framing, and
2. Risk assessment consisting of a reﬁned
assessment starting from the Phase 1
outcome.
Three information-gathering pillars and a
risk characterization pillar are situated
across both phases. Each of these four pillars
can be regarded as a toolbox containing
data-generating tools (information--
gathering pillars) or risk assessment tools
(risk characterization pillar) that range from
relatively simple to very complex.
• Iterative/adaptive structure
• Transparency/Communication
ECHA/RIVM/JRC read-across and
grouping framework for
nanomaterials (ECHA, JRC and
RIVM, 2016)
The strategy for using data between
nanoforms consists of 6 steps:
1. Identiﬁcation of the nanoforms
2. Initial grouping of the nanoforms
3. Identiﬁcation of avalable data and data
gaps
4. Identiﬁcation of potential source
nanoforms
5. Substantiate hypothesisAssess new data
• Provides a structured approach to guide
registrants and regulators on how to apply
grouping and read-across concepts to
nanoforms
• Compliant with the REACH requirements
for CSA
• Can help to reduce testing
• Considers data quality in the grouping and
read-across processes
• Strongly depends on data on physicochem-
ical parameters of each nanoform, which
are often unavailable
• Requires high quality of the data for moni-
toring of physicochemical parameters dur-
ing testing, which is difﬁcult to ensure or
derive from the published literature
• Limited to read-across for hazard endpoints
ECETOC decision analytical
framework to facilitate the
grouping of nanomaterials
(DF4nanoGrouping) (Arts et
al., 2015a)
DF4nanoGrouping consists of 3 tiers to
assign MNs to 4 main groups:
1. Soluble MNs
2. Biopersistent high aspect ratio MNs
3. Passive MNs, and
4. Active MNs
• Covers all relevant aspects of MNs life cy-
cles and biological pathways such as intrin-
sic material and system-dependent
properties, biopersistence, uptake and
biodistribution, cellular and apical toxic ef-
fects
• Use, release and route of exposure are ap-
plied as “qualiﬁers” in order to determine if
MNs can be released from a product matrix
• Groups MNs by their speciﬁc modes of ac-
tion that result in apical toxic effects
• Still does not cover environmental scenari-
os
• The decision analytical framework is still
rather conceptual
ECHA Guidance on RA of MNs
under REACH (ECHA, 2012c,
ECHA, 2012b, ECHA, 2012d,
ECHA, 2012e, ECHA, 2012f,
ECHA, 2012a)
The REACH CSA consists of 6 steps:
1. Human health hazard assessment
2. Human health hazard assessment of
physicochemical properties
3. Environmental hazard assessment
4. PBT and vPvB assessment
5. Exposure assessment
6. Risk characterization
• It implements the regulatory RA of
chemicals to MNs and provides guidance
on the adaptations
• It provides guidance on physicochemical
parameters and analytical methods
• It provides advice on e.g. test sample prep-
aration and interference with speciﬁc
assays, applicability of non-testing
methods, dose metrics, extrapolation and
assessment factors is provided
• It covers all uses of the MNs along the
lifecycle (from production to end of life)
• Grouping, read-across, and exposure-based
waiving are in principle applicable
• No legal deﬁnition of ‘nanomaterial’ (MNs
implicitly covered by the REACH deﬁnition
of ‘substance’)
• Nano-speciﬁc information requirements
are not in the legal text but in guidance
• It provides guidance on how to partially
address criticalities and uncertainties but
not on their quantiﬁcation
EFSA Guidance on RA of MN in
the food and feed chain (EFSA,
2011)
The framework is a decision tree based on
the following steps:
1. Physicochemical characterization
2. Determine exposure scenarios
3. Read-across to non-nanoform and/or
speciﬁc testing
4. Hazard identiﬁcation and hazard
characterization
5. Exposure assessment
6. Risk characterization
• Legal deﬁnition of ‘engineered
nanomaterial’
• It implements the regulatory RA of
chemicals to MNs and provides guidance
on the adaptations
• It provides list of physicochemical parame-
ters
• It recommends physicochemical character-
ization of MNs in ﬁve stages: as
manufactured, as delivered for use in
products, as present in food/feed matrix, as
used in toxicity testing, as present in bio-
logical ﬂuids and tissues
• It allows for reduced testing when no ex-
posure to MNs is veriﬁed (no migration
from packaging, complete degradation/-
dissolution)
• It provides guidance on six different toxici-
ty testing strategies
• Read-across to non-nanoform is suggested
in some cases
• Nano-speciﬁc information requirements
are not in the legal text but in guidance
• It provides guidance on how to partially
address criticalities and uncertainties but
not on their quantiﬁcation
SCCS Guidance on RA of MN in
cosmetics products (SCCS,
2012)
The framework is a decision tree based on
the following steps:
1. Physicochemical characterization
2. Exposure assessment considering possi-
ble routes
3. Hazard identiﬁcation and dose-response
characterization
• Legal deﬁnition of ‘nanomaterial’
• It implements the regulatory RA of
chemicals to MNs and provides guidance
on the adaptations
• It provides list of physicochemical parame-
ters
• It recommends physicochemical character-
ization of MNs in three stages: as
• Nano-speciﬁc information requirements
are not in the legal text but in guidance
• It provides guidance on how to partially
address criticalities and uncertainties but
not on their quantiﬁcation
(continued on next page)
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Table 2 (continued)
Framework Structure Strengths Areas for improvement
4. Risk assessment manufactured, as present in cosmetic
formulation, as used in toxicity testing,
• RA of MNs may be driven by exposure
considerations (translocation, systemic
absorption)
• It allows for use of validated alternative
methods for hazard assessment of MNs
REACH Annexes laying out the standard information requirements for registrants are currently under review for nanomaterials by the European Commission.
42 D. Hristozov et al. / Environment International 95 (2016) 36–53nano-relevance criteria: i) particles are not (water) soluble; ii) they are
synthetically produced and not unintentionally released from e.g. in-
complete combustion; iii) the size of the primary particles is smaller
than 100 nm and/or the speciﬁc surface area of nanopowders is larger
than 60 m2/g (Duuren-Stuurman et al., 2011).
Out of the reviewed tools only Paik et al. (2008) and
Stoffenmanager Nano were tested in real case studies. Paik et al.
(2008) assessed four representative MNs activities for their risk
level and potential control schemes, while Zalk et al. (2009) used
the same tool to address twenty-seven real industrial activities.
Stoffenmanager Nano was tested in some of the industrial work-
places studied in the EU-funded SCAFFOLD project. Overall, the
tools performed as expected, but the uncertainties in their applica-
tion were not addressed.Table 3
Evaluation of the selected nanospeciﬁc frameworks according to 6 criteria relevant for RA.−=
Framework
Criteria
Nano-speciﬁc
requirements
Life
cycle
thinking
Pre-assessment
phase
Exposure
driven
approach
Nanotechnology Risk Governance
(RENN and ROCO, 2006)
− ± + +
Nano Risk Framework
(Environmental Defense and
DuPont, 2007)
+ ± + ±
SCENIHR (2007, 2009) + ± + +
Nano-Life Cycle Risk Analysis
(Nano-LCRA) (Shatkin, 2008)
− ± + +
Nanomaterials under REACH
(Pronk et al., 2009)
+ + + −
Comprehensive Environmental
Assessment (CEA) (Davis et al.,
2010)
− + ± −
MARINA Framework (Bos et al.,
2015)
+ + + +
ECHA/RIVM/JRC read-across and
grouping framework for
nanomaterials (ECHA, JRC and
RIVM, 2016)
+ ± − −
ECETOC decision analytical
framework to facilitate the
grouping of nanomaterials
(DF4nanoGrouping) (Arts et al.,
2015a)
+ + − −
ECHA Guidance on RA of MNs
under REACH (ECHA, 2012c,
ECHA, 2012b, ECHA, 2012d,
ECHA, 2012e, ECHA, 2012f,
ECHA, 2012a)
+ + + ±
EFSA Guidance on RA of MNs in
the food and feed chain (EFSA,
2011)
+ + + +
SCCS Guidance on RA of MNs in
cosmetics products (SCCS,
2012)
+ + + +3.2.1.2. Risk screening tools. The risk screening tools are also easy to
use, they have relatively low data requirements and the majority of
them can cover more than one lifecycle stages (e.g. occupational sce-
narios in both the production and end-of-life stages). Most of them
are qualitative or semi-quantitative, but also quantitative risk scor-
ing procedures were developed. Speciﬁcally, the Precautionary Ma-
trix for Synthetic Nanomaterials (Höck et al., 2010) is a semi-
quantitative approach designed to estimate effects, exposure,
nano-relevance, and speciﬁc framework conditions in workplace,
consumer and environmental settings. Scores are assigned to several
criteria and they are aggregated into a “precautionary need” index.
The Tool for MNs-Application Pair Risk Ranking (TEARR) (Grieger
et al., 2015) is another semi-quantitative approach developed by
the U.S. Army Corps of Engineers. It uses a variety of inputCriterion not fulﬁlled; + = Criterion fulﬁlled; ± = Criterion not fully fulﬁlled.
Iterative/adaptive
structure Transparency/Communication
Documented
applications
Allowing
for/giving
directions on
grouping and
read-across
± ± ± −
+ + ± −
± ± − −
± ± ± −
± ± ± −
± + + −
+ + − +
± + − +
± + − +
± + ± ±
± + ± ±
± + ± ±
Table 4
Evaluation of the identiﬁed tools according to 6 relevant criteria.−=Criterion not fulﬁlled;+=Criterion fulﬁlled;±=Criterion not fully fulﬁlled; /= Criterion not applicable/relevant;
(P) = Tool under development in an on-going project.
Tool
Criteria
Type of tool
Protocol
(P)/Modelling
(M)/Database
(D)
Easy
to
use
Quantitative
estimation/information
Uncertainty
analysis
Life cycle
perspective
Documented
applications
Assessment
tier
Maynard (2007) Control banding M + − − − − Low
Nanomaterials Control Banding Tool (Paik et
al., 2008) (Zalk et al., 2009)
Control banding M + − − − − Low
ANSES Control Banding Tool (Ostiguy et al.,
2010)
Control banding M ± − − − + Low
Stoffenmanager Nano (Duuren-Stuurman et
al., 2011)
Control banding M + − − − + Low
Precautionary Matrix for Synthetic
Nanomaterials (Höck et al., 2010)
Human and
environmental risk
screening
M + − ± ± − Low
Multi-criteria Acceptability Analysis
(SMAA-TRI) Tool (Tervonen et al., 2009)
Human and
environmental risk
screening
M − + + ± ± Low
(P) Tool for ENM-Application Pair Risk
Ranking (TEARR) (Grieger et al., 2015)
Human risk screening P/M + ± − ± − Low
Hristozov et al. (2014) Human hazard
screening
M − + + ± + Low
Hristozov et al. (2014) Occupational exposure
screening
M − + + ± + Low
Hristozov et al. (2016) Human risk screening M − + + ± + Low
(P) MARINA Species Sensitivity
Distributions (SSD) Tool (Semenzin et al.,
2015)
Environmental risk
assessment
M + + + − + Low/high
(P) NanoSafer (Jensen et al., 2013) Occupational exposure
assessment
M + + − + + Low
NanoRiskCat (Hansen et al., 2013) Consumer exposure
assessment
M + − − − + Low
Advanced REACH Tool (ART) (Fransman et
al., 2009)
Occupational exposure
assessment
M + + − − + High
(P) Dermal Advanced REACH Tool (DART)
(Gorman et al., 2012)
Occupational/consumer
exposure assessment
M + + − − − Low/high
(P) SUN tiered occupational and consumer
exposure model
(www.sun-fp7.eu/)
Occupational/consumer
exposure assessment
M + ± + − + Low/high
(P) MARINA Occupational exposure
experiments
P − + / / + Low/high
Boxall et al. (2008) Environmental
fate/exposure
assessment
M ± + − ± + Low
Mueller and Nowack (2008) Environmental
fate/exposure
assessment
M − + ± + + Low
Stochastic Materials Flowmodel (Gottschalk
et al., 2010a, 2010b, Sun et al., 2014,
Gottschalk et al., 2009, Gottschalk et al.,
2013, Gottschalk et al., 2011)
Environmental
fate/exposure
assessment
M − + + + + Low/high
(P) CEINT (DALE et al., 2015)
(http://www.ceint.duke.edu/)
Environmental
fate/exposure
assessment
M − + − + + Low/high
(P) CEINT/TINE (Dale et al., 2013)
(http://www.ceint.duke.edu/)
Environmental
fate/exposure
assessment
M − + − + + High
Ardvisson et al. (2011) Environmental
fate/exposure
assessment
M − + − / − High
Quik et al. (2014) Environmental
fate/exposure
assessment
M − + − / − High
O'brien and Cummins (2011) Environmental
fate/exposure
assessment
M − − + + ± Low
Money et al. (2012) Environmental
fate/exposure
assessment
M − + + / − Low
SimpleBox4Nano (Meesters et al., 2014) Environmental
fate/exposure
assessment
M − + − + + Low
(P) MARINA (Tuoriniemi et al., 2014,
Cornelis and Hassellov, 2014)
Environmental
behaviour, fate and
exposure experiments
P − + / / + High
(continued on next page)
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Table 4 (continued)
Tool
Criteria
Type of tool
Protocol
(P)/Modelling
(M)/Database
(D)
Easy
to
use
Quantitative
estimation/information
Uncertainty
analysis
Life cycle
perspective
Documented
applications
Assessment
tier
(P) MARINA (Kühnel and Nickel, 2014) Environmental
behaviour, fate and
exposure experiments
P − + / / + Low
(P) NANEX/MARINA
(www.nanex-project.eu/)
Exposure scenario
library, occupational
setting
D + ± / − / Low
(P) NECID (http://www.perosh.eu/) Exposure scenario
database, occupational
setting
D + ± / + / Low/high
Physiologically-based pharmacokinetic
(PBPK) models (Riviere, 2014)
Kinetic models for
internal exposure
assessment
M − + − − + Low/high
Short Term Inhalation Studies (Klein et al.,
2012)
In vivoIkinetic tools for
human exposure and
hazard assessment
P − + / / + Low/high
(P) SUN Short Term Oral Studies In vivoIkinetic tools for
human exposure and
hazard assessment
P − + / / + Low/high
(P) STAR (Yokel et al., 2009, Yokel et al.,
2012, Hardas et al., 2010, Dan et al., 2011)
In vivoIkinetic tools for
human exposure and
hazard assessment
P − + / / + Low/high
(P) MARINA (Lammel et al., 2013, Lammel
and Navas, 2014)
In vitro and in vivo
tools for human hazard
assessment
P − + / / + Low/high
(P) NanoVALID (http://www.nanovalid.eu/) In vivo tools for human
and environmental
hazard assessment
P − + / / + Low
(P) NanoVALID (Oostingh et al., 2013, Kohl
et al., 2011)
In vitro tools for human
hazard assessment
P − + / / + Low/high
(P) NANOMILE (Madani et al., 2012)
(http://nanomile.eu-vri.eu/)
In vitro tools for human
hazard assessment
P − + / / + Low
(P) EURO-NanoTox (Mrakovcic et al., 2013,
Mrakovcic et al., 2014)
In vitro tools for human
hazard assessment
P − + / / + Low/high
In Silico tools, incl. Quantitative
Nano-structure Activity Relationships
(QNAR) (Burello and Worth, 2011a,
Burello and Worth, 2011b, Puzyn et al.,
2011, Puzyn et al., 2009a, Puzyn et al.,
2009b, Toropov et al., 2007, Toropov and
Leszczynski, 2006, Liu et al., 2013b, Liu et
al., 2014, Liu et al., 2013a, Gómez et al.,
2013)
In silico tools for hazard
assessment
M − + − − + low/high
(P) MODERN QNAR (Liu et al., 2014, Liu et
al., 2013a, Liu et al., 2013b)
In silico tools for hazard
assessment
M − + + − + Low/high
(P) NANOREG Physicochemical
characterization
P − + / / + Low/high
(P) MARINA Physicochemical
characterization
P − ± / / − Low
(P) NanoVALID
(http://www.nanovalid.eu/)
Physicochemical
characterization
P − + / / + Low
(P) NANOMILE (Madani et al., 2012) Physicochemical
characterization
P − + / / + Low/high
(P) NANODEFINE Physicochemical
characterization
P − + / / + Low/high
(P) NANOLYSE
(http://www.nanolyse.eu/default.aspx)
Physicochemical
characterization
P − + / / + Low/high
(P) NANOSAFER 2
(http://nanosafer.i-bar.dk/)
RA model M − ± ± − − Low/high
(P) LICARA (Van Harmelen et al., 2016) Decision support tool M + ± − + − Low
(P) SUN DSS Decision support tool M + + + + + Low/high
(P) GUIDEnano DSS
(http://www.guidenano.eu/)
RA model M + + + + − Low/high
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size, density, composition, solubility, and aggregation), environmen-
tal fate indicators (e.g. partitioning coefﬁcients, persistence), reac-
tivity indicators (e.g. surface charge), application-speciﬁc data (e.g.
numbers of products, exposed individuals), and use patterns to
rank MNs in terms of human health risk. Similarly, Tervonen et al.
(2009) developed a semi-quantitative tool for health andenvironmental risk classiﬁcation of MNs based on Stochastic Multi-
Criteria Acceptability Analysis (SMAA-TRI). It is based on a set of per-
formance criteria that measure the toxicity of the pristine materials,
their physicochemical characteristics and expected environmental
impacts (Tervonen and Figueira, 2008). Hristozov et al. (2014) de-
veloped the ﬁrst quantitative Multi-Criteria Decision Analysis
(MCDA) methodology for human health hazard identiﬁcation of
45D. Hristozov et al. / Environment International 95 (2016) 36–53MNs, which incorporated data quality evaluation of the available
dataset, based on the criteria adequacy, reliability, statistical and
toxicological signiﬁcance. Moreover, Hristozov et al. (2014) pro-
posed a quantitative MCDA approach for prioritization of nano-spe-
ciﬁc exposure scenarios in occupational settings, and Hristozov et
al. (2016) developed a quantitative MCDA methodology for human
health risk ranking of MNs.
Some of these tools are capable of assessing uncertainties. The Pre-
cautionary Matrix for Synthetic Nanomaterials uses a “speciﬁc frame-
work conditions” criterion that represents uncertainties resulting from
knowledge gaps with respect to the origin of the MNs, their character-
istics and uses. The tool by Tervonen et al. (2009) is able to conduct
quantitative uncertainty analysis, while the models by Hristozov et al.
(2014, 2016) perform probabilistic Monte Carlo sensitivity and uncer-
tainty analyses. These stochastic analyses demonstrated that variations
in the input parameters (i.e. exposure concentrations) did not signiﬁ-
cantly affect the obtained results. However, the considerable uncertain-
ty in the input data called for the careful interpretation of the obtained
results.
While they may be suggestive of innovative strategies for risk pri-
oritization, the majority of the above risk screening tools have not
been thoroughly tested yet and therefore their robustness has not
been conﬁrmed (Grieger et al., 2012). One exception is the approach
by Tervonen et al. (2009), which was applied to fullerenes, cadmi-
um-selenium quantum dots, silver (Ag) and aluminum (Al) MNs,
and multi-walled carbon nanotubes (CNTs). The input data was ei-
ther derived from the literature or from expert judgement. In addi-
tion, the tools by Hristozov et al. (2014, 2016) were applied in real
industrial case studies involving nanoscale Titanium dioxide (TiO2),
Ag, Zinc oxide (ZnO) and CNTswith data derived from the EU-funded
projects ENPRA, NANEX and MARINA. The application of the above
approaches demonstrated highest risks in exposure scenarios con-
cerned with handling of large amounts of dry powders (e.g. bag/bin
ﬁlling, manual un/loading, dumping). Scenarios, where the risks
were relatively high involved handling of dry powders in smaller
quantities (e.g. transferring of materials for solution preparation,
weighing). In contrast, wet chemistry and laser ablation synthesis
processes posed negligible risks due to very low emissions.
3.2.2. Exposure assessment tools
3.2.2.1. Occupational and consumer exposure tools. Several quantitative
exposure models for chemicals were developed as a response to re-
quirements under the European REACH regulation. These conservative
easy-to-use Tier 1 tools include ECETOC TRA, MEASE, Stoffenmanager,
ConsExpo, EMKG-EXPO-TOOL and RISKOFDERM. The majority of them
estimate occupational inhalation exposure, while ECETOC TRA and
CONSEXPO also address consumer inhalation and dermal exposure.
The Advanced REACH Tool (ART) is a Tier 2 inhalation model, while
the Dermal Advanced REACH Tool (DART) (Gorman et al., 2012) esti-
mates dermal exposure. Unfortunately, none of these tools were cali-
brated for MNs, but for some of them this is currently work in
progress. For instance DART is currently being tailored to MNs in the
SUN project, which develops a tiered qualitative to quantitative frame-
work and a tool to assess not only inhalation, but also dermal and der-
mal-to-oral occupational and consumer exposure to MNs.
In addition, a number of nano-speciﬁc qualitative or semi-quantita-
tive tools were developed for consumer (Hansen et al., 2011), and occu-
pational (Genaidy et al., 2009, Paik et al., 2008, Duuren-Stuurman et al.,
2011, Giacobbe et al., 2009) exposure assessment. Some prominent ex-
amples are Stoffenmanager Nano (Duuren-Stuurman et al., 2011) and
NanoSafer (Jensen et al., 2013), which consider personal exposure in
their estimations, while NanoSafer bases its assessment on time-re-
solved exposure estimates and allows evaluation of both acute and
chronic exposure. These approaches are currently being upgraded in
the SUN project to incorporate important aerosol dynamic processesand uncertainty analysis functionalities. Aerosol dynamic modelling is
a major step forward in the exposure assessment of MNs, but is
constrained by the lack of well-characterised exposure scenarios, in-
cluding sufﬁcient data on source strengths, workplace measurements
and contextual information.
Such scenarios have been developed in EU-funded research projects
such as NANEX,MARINA, and SUN, and are compiled in data libraries. In
order to progress from individual libraries to exposure data infrastruc-
ture the Partnership for European Research on Occupational Safety a
Health (PEROSH) developed the Nano Exposure & Contextual Informa-
tion Database (NECID). NECID is intended to support its users to fulﬁll
scientiﬁcally agreed requirements on information gathering for occupa-
tional exposure assessment of MNs, and to provide a general overview
of MNs exposure measurements in different scenarios. Such a database
is useful not only for exposure modelling, but also for read-across of in-
formation from one scenario to another, which can enable RA in data-
poor situations.
3.2.2.2. Environmental fate and exposure tools.Onemajor drawback in the
ecological RA of MNs are the difﬁculties to detect them in natural envi-
ronments due to lack of adequate tools to discriminate them from back-
ground nanoparticles. In order to enable environmental exposure
assessment ofMNs in the absence of reliablemeasurements, several en-
vironmental fate models were developed, which can be broadly catego-
rized as “material ﬂow” and “mechanistic” fate models.
3.2.2.3. Material ﬂow models. The material ﬂow analysis (MFA) models
developed for MNs are based on the standard MFA methodology
(Brunner and Rechberger, 2004) and the framework for CSA as outlined
in the REACH guidance document (ECHA, 2010). The majority of these
tools are quantitative and are not easy to apply by non-experts. In
most of them releases into the environment are evaluated from lifecycle
perspective and they use “transfer coefﬁcients”, derived from empirical
data and informed assumptions about the transport of MNs between
technical and environmental compartments, to estimate Predicted En-
vironmental Concentrations (PECs) (Gottschalk et al., 2010b, Sun et
al., 2014, Gottschalk et al., 2009, 2013, 2011).
Boxall et al. (2008) developed the ﬁrst quantitative model to esti-
mate PECs for MNs. It is a rather simple system of mathematical algo-
rithms, which requires data on MNs production volumes and uses to
estimate concentrations in water, soil, and air. Mueller and Nowack
(2008) developed the approach further by assuming steady state condi-
tions and homogeneous concentrations in the environmental compart-
ments based on recommendations from the REACH guidance for CSA
(Echa, 2010). In order to address some of the limitations of the above
tools and strengthen their capacity to account for the high input data
andmodelling uncertainties, Gottschalk et al. (2010a) proposed a prob-
abilistic model involvingMonte Carlo, Bayesian andMarkov Chain anal-
yses. This model uses input parameters, such as nano-speciﬁc
production and consumption volumes, fate pathways and transfer coef-
ﬁcients to derive probability distributions of possible PECs. Several other
MFA-based seminal variations of the above models were published
(Blaser et al., 2008, Wigger et al., 2015, Keller et al., 2013, O'brien and
Cummins (2011)). Some signiﬁcant limitations of these tools are that
relevant compartments, such as groundwater and sediments, and cer-
tain essential processes, such as aggregation/agglomeration, sedimenta-
tion, re-suspension, degradation and transformation, were not
considered in the estimations.
The approach byO'brien and Cummins (2011) represents one of the
ﬁrst attempts to combine MFA and colloidal chemistry. The U.S. Center
for Environmental Implications of Nanotechnology (CEINT) developed
a similar tool to estimate environmental concentrations of MNs in sur-
face waters and sediments (DALE et al., 2015). Some processes consid-
ered by the CEINT model include runoff from crop soils, sewage
treatment plant efﬂuent loads to the stream, ﬂow-dependent sediment
transport (settling and re-suspension) and its impact on nanoparticle
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ticle transformations in the water column and the sediment as a func-
tion of spatiotemporal variation in oxygen, sulﬁde and temperature.
Themajority of the reviewedMFAmodels have the ability to account
in some ways for the large uncertainties in regards to the releases of
MNs from products and/or industrial processes, production volumes,
and use scenarios. Some of them considered ranges of best-case, realis-
tic and worst-case scenarios in estimating exposure instead of generat-
ing highly uncertain, and therefore misleading PECs for single scenarios
(Mueller and Nowack, 2008, Gottschalk et al., 2010b, 2011, Gottschalk,
2013). The more recent tools used probabilistic (e.g. Monte Carlo)
methods to characterize the uncertainty and variability in the obtained
results (Gottschalk et al., 2010a, O'brien and Cummins, 2011, Gottschalk
et al., 2011, Gottschalk, 2013).
Most of the MFAmodels were demonstrated in case studies. The tool
by Boxall et al. (2008) for example was applied tomodel the exposure of
C60 fullerene and nanoscale Ag, Al, TiO2, ZnO, Latex and Hydroxyapatite
in the UK. Similarly, the model by Mueller and Nowack (2008) was ap-
plied to calculate PECs for nanoscale Ag, TiO2 and CNT released into air,
soil and water in Switzerland. Both assessments were based on signiﬁ-
cant assumptions about market penetrations and consumer uses and
lacked any analysis of the associated uncertainties. The tool by O'brien
and Cummins (2011) was applied for estimating exposure to nanoscale
TiO2, Ag and CeO2 released from paints, food packaging and fuel addi-
tives, but unlike the above studies this assessment involved uncertainty
analysis. The Gottschalk et al. (2010a) model has been continuously up-
dated in theMARINAand SUNprojects and its newversionswere used to
calculate concentrations of nanoscale TiO2, ZnO, Ag, CNT and fullerenes
in environmental and technical compartments by applying the newest
data on MNs production volumes, release from products and material
ﬂows (Gottschalk et al., 2013, Sun et al., 2014). These analyses showed
that the production volume and the compounds' inertness are crucial
factors determining their ﬁnal environmental concentrations. In the
SUN project the model was upgraded to consider important end-of-life
scenarios such as incineration and recycling (Caballero-Guzman et al.,
2015, Walser and Gottschalk, 2014), where signiﬁcant release of MNs
is expected to occur. CEINT tested their model with nanoscale ZnO and
Ag using the James River Basin in Virginia as a case study (DALE et al.,
2015).
3.2.2.4. Dynamic models. There are a number of quantitative models,
based on insights from colloidal chemistry, which account for the ag-
glomeration/aggregation, sedimentation, re-suspension and dissolution
dynamics ofMNs (Ardvisson et al., 2011, Meesters et al., 2014, Money et
al., 2012, Dale et al., 2013). The majority of these approaches cannot be
characterised as user-friendly tools. One exception is the
SimpleBox4Nano (Meesters et al., 2014), which is a screening-level
fate model that considers the transport and concentrations of MNs in
and across air, rain, surface waters, soil, and sediment, and accounts
for nano-speciﬁc processes such as agglomeration/aggregation, attach-
ment, and dissolution. The model is implemented as a user-friendly
Microsoft Excel spreadsheet, supported by numerical computations in
R, which are linked to the spreadsheet via RExcel. It solves mass balance
equations based on ﬁrst-order rate constants bymeans of simplematrix
algebra. The output of the model is mass concentrations of MNs as free
dispersive species, heteroaggregates with natural colloids, and larger
natural particles in each compartment as function of time and in steady
state.
Similarly, the model by Ardvisson et al. (2011) provides the means
to estimate particle number concentrations in the aquatic environments
resulting fromprocesses such asmaterials inﬂow, homo- and hetero ag-
glomeration/aggregation and sedimentation, which are considered
driving forces behind the transport of MNs inwaters and their potential
elimination from them. In order to achieve similar results, in addition to
these phenomena, the model by Quik et al. (2014) takes into consider-
ation also processes such as advection, volatilisation, chemicaldegradation, dissolution, and deposition, which makes it less strictly
nano-speciﬁc and therefore applicable also to chemicals.
Money et al. (2012) adopted a different quantitative approach ap-
plying Bayesian networks in combination with expert elicitation as a
tool for nanomaterial risk forecasting to develop a baseline probabilistic
model that incorporates nano-speciﬁc characteristics and environmen-
tal parameters, alongwith elements of exposure potential, hazards, and
risks fromMNs. The Bayesian nature of FINE (Forecasting the Impacts of
Nanomaterials in the Environment) allows for updating as newdata be-
come available.
CEINT, in collaboration with the Transatlantic Initiative for Nanotech-
nology and the Environment (TINE), developed a model to predict the
distribution and speciation of both nanoscale and ionic Ag in freshwater
sediments as a function of seasonally variable organic carbon, dissolved
oxygen, sulﬁde, and temperature (Dale et al., 2013). The authors used
concepts from colloidal chemistry to apply a conventional mass balance
approachby adapting amodel of cadmiumspeciation anddistributionde-
veloped by Di Toro et al. (1996). Themodel was calibrated to data collect-
ed from Ag-dosed large-scale freshwater wetland mesocosms run by the
CEINT. It was designed speciﬁcally for Ag, but the same principles could
also be applied to other MNs (Dale et al., 2013).
The models by Ardvisson et al. (2011) and Quik et al. (2014) were
discussed on a conceptual level only and were never applied in case
studies. In contrast, the SimpleBox4Nano tool was demonstrated in sce-
narios for Switzerland, and evaluated the impact of transport processes
on the ﬁnal PECs. The CEINT/TINE tool was tested with nanoscale Ag
data from freshwater wetland mesocosms. Similarly, the tool by
Money et al. (2012) was applied to estimate nano Ag concentrations
in aquatic environments (Money et al., 2012).
3.2.2.5. Behaviour and fate experiments. The abovemodels need empirical
data for validation. The environmental fate and behaviour of MNs are
determined by several processes, which depend not only on the charac-
teristics of theMNs but also on themedia embedding them (Tiede et al.,
2008). In aquatic systems, important processes affecting the transport,
transformation and bioaccumulation of MNs include aggregation and
disaggregation, dissolution, precipitation, diffusion, advection, sedi-
mentation etc. (Ardvisson et al., 2011, Quik et al., 2014). MNs character-
istics such as surface afﬁnity are the driving forces for dissolution and
biotransformation processes as well as for the complex interactions
with abiotic and biological surfaces (Quik et al., 2014). It is important
to understand how these characteristics can be linked to the nano-spe-
ciﬁc models described above as well as to certain partitioning and bio-
availability models established for conventional chemicals. In order to
achieve this more data and mechanistic knowledge need to be generat-
ed. Onemajor reason for the current lack of such data is the deﬁciency of
experimental protocols for characterization of MNs in (complex) envi-
ronmental media, which has emerged from difﬁculties to distinguish
the MNs from background particles of similar chemical composition.
Several projects are currently developing tools to identify key character-
istics of MNs that affect their fate based on combinations of MNs label-
ing and advanced measurement techniques such as X-ray absorption
spectroscopy (XAS), Atomic force microscopy (AFM), Field ﬂow frac-
tionation (FFF), and Inductively coupled plasma mass spectrometry
(ICP-MS).
One of these projects was the EU-funded MARINA, where re-
searchers developed protocols to study the mobility of MNs in order
to predict their exposure concentrations in different environmental
compartments (i.e. soil, sediment and freshwater) with the idea to
turn these procedures into standards. Some of these protocols are
based on the OECD Test Guideline (TG) 312: Leaching in Soil Columns,
and involve soil column chromatography in disturbed soil to determine
the leachingpotential of the test substance, and the leachingpotential of
transformation products in soils under controlled laboratory conditions.
These protocols involve detailed physicochemical characterization of
the MNs and the exposure media by means of advanced analytical
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(Kühnel and Nickel, 2014). Other methods aim to measure extremely
low number concentrations of MNs in complex environmentalmatrices
by single particle ICP-MS (Tuoriniemi et al., 2014, Cornelis and
Hassellov, 2014).
Another key EU-funded project developing the understanding of the
release, behaviour, fate and exposure to MNs is SUN. The SUN partners
collect nanoscale fragments released from seven real industrial prod-
ucts at different lifecycle stages in order to characterize their physico-
chemical properties in biological (cell culture) and environmental
(soil, sediment andwater)media. The project studies the physicochem-
ical transformations of MNs during release and in the environment in
order to identify the properties of those MNs that reach environmental
organisms or humans. SUN is also actively contributing to the work of
the OECD on developing standard protocols for environmental fate in
support to the RA of MNs. Speciﬁcally, the project is contributing to
the implementation of the OECD TG 105 on water solubility for MNs.3.2.2.6. Kinetic tools for estimation of human internal exposure. Computa-
tional physiologically-based pharmacokinetic (PBPK)models can incor-
porate toxicokinetic data along with species-speciﬁc physiological
properties to study the post-exposure absorption, distribution, metabo-
lism and excretion (ADME) of MNs (Lee et al., 2009, Riviere, 2009,
Lankveld et al., 2010, Van Kesteren et al., 2014). Speciﬁc PBPK tools
were proposed by Lee et al. (2009) for quantum dots, by Lankveld et
al. (2010) for nano Ag, and by Van Kesteren et al. (2014) for nano
SiO2. A generic PBPK model for MNs was developed by IOM in collabo-
ration with the U.S. NIOSH agency in the context of the EU FP7 ENPRA
and MARINA projects (Riviere, 2014). It is an adaptation and extension
of an earlier PBPK model for larger particles, which was calibrated with
data from the EU ENPRA, NANOMMUNE andNANOTEST projects. Such a
model can be used to characterize theADMEproﬁles of theMNs for a di-
verse range of species based on particle type and physicochemical prop-
erties. Moreover, it can help to develop MN-speciﬁc uncertainty factors
for interspecies differences in kinetics (e.g. between rodents and
humans). PBPK modelling may facilitate extrapolation in exposure du-
ration, e.g. tissue concentration levels for chronic exposure. However,
as we do not fully understand the factors driving the MNs distribution
between blood/plasma and tissues, extrapolations should be considered
and interpreted with caution.
There is lack of reliable experimental data to validate nano-speciﬁc
PBPK models. In order to ﬁll this gap, several projects have developed
and/or applied in vivo kinetic protocols. For instance, the U.S. STAR pro-
ject developed methods to determine the distribution, persistence,
translocation on and biotransformation of metal oxideMNs, their toler-
ability, and effects, focusing on oxidative stress endpoints (Yokel et al.,
2009, Yokel et al., 2012, Hardas et al., 2010). This tool is an in vivo pro-
tocol including comprehensive physicochemical characterization for
properties such as size, shape, zeta potential, extent of surface coating,
and solubility. It includes investigation of multiple oxidative stress and
inﬂammatory markers (Yokel et al., 2009, Yokel et al., 2012, Dan et al.,
2011). Moreover, the EU-funded SUN project adapted and applied the
Short-term Inhalation Studies (STIS) protocol developed in the
NANOSAFE2 and NANOCARE projects (Klein et al., 2012). In addition,
SUN developed a novel Short-term Oral Studies (STOS) protocol. Both
STIS and STOS involve 5-day exposure with post-exposure examina-
tions for up to 28 days and consider the assessment of progression or re-
gression of effects and potential translocation to secondary organs,
which are important aspects, currently not covered in the OECD TGs
412 and 413 (Klein et al., 2012). OECD TG 412 and 413 covermore end-
points and a longer exposure duration, and being OECD TG they fall
under the legally binding “Mutual Acceptance of Data” principle that fa-
cilitates the international acceptance of information for the safety as-
sessment of chemicals. Currently, the OECD TG programme reviews
inhalation testing for MNs under the project: “Amendments to theInhalation Test Guidelines and Guidance to Accommodate
Nanomaterials”, which is led by U.S. EPA.
3.2.3. Hazard assessment tools
3.2.3.1. In vivo and in vitro toxicity testing tools. The OECD Testing Pro-
gramme has evaluated the applicability of the TGs for conventional
chemicals to MNs (OECD, 2009). Furthermore, it undertook to co-ordi-
nate the testing of a set of MNs, and the outcomes of the experiments
were published (OECD, 2016). Preliminary results have shown that
most TGs are suitable for MNs but in some cases adaptations may be
needed to address certain nano-speciﬁc characteristics. Therefore, the
programme has started to work on adapting these TGs to MNs and to
develop nano-speciﬁc TGs and guidance documents. In this context, in
vivo and in vitro protocols for investigating the hazards of MNs have
been developed and validated in a large number EU-funded projects
(cf. Nanosafety Cluster Compendium). As a result a coherent hazard
proﬁle of MNs has emerged, demonstrating that reactive oxygen spe-
cies, oxidative stress andmodiﬁed inﬂammatory responses play impor-
tant roles in their animal and cellular toxicity (Hristozov et al., 2014).
The results of the above projects also show relationships between key
physicochemical characteristics, modes of action and biological re-
sponses, indicating that factors such as surface area, reactivity, charge,
solubility, shape and composition are all key.
Amajor gap in the ﬁeld of human nanotoxicology is the lack of long-
term inhalation and ingestion studies. In this context NANOREG per-
formed a two-year inhalation study with CeO2, while SUN researchers
transformed existing single and multi-species models to tools for esti-
mating long-term and multi-generation environmental effects of MNs
(Castro-Ferreira et al., 2014, Chen et al., 2014, Van Ommen Kloeke et
al., 2014). Sewage Treatment Plants (STP) are among the ﬁrst affected
by releasedMNs (Yang et al., 2012), therefore SUNdevelops a tool to as-
sess the possible impairment of STP biological function.
MARINApartners developed in vitro tools intended to determine the
concentrations of MNs causing toxicity to cells and to establish basic
mechanisms of toxicity such as alteration of e.g. cellmembranes,metab-
olism and clearancemechanisms (Lammel et al., 2013). These tools aim
to prioritizeMNs for further testing and to determine realistic exposure
concentrations to be applied in in vivo testing. In addition, according to
the tools developers their outputs could be used directly for environ-
mental RA in aquatic environment with conservative correction factors
to account for in vitro–in vivo differences (Lammel and Navas, 2014).
NanoVALID researchers developed validated in vitro screening
methods for MNs, which were included in decision trees to support op-
timal in vivo test design. The reproducibility of these tests across labora-
tories was checked by round-robins. Moreover, NanoVALID partners
developed Enzyme-linked Immunosorbent Assay (ELISA) and Reverse
Transcription Polymerase Chain Reaction (RT-PCR) assay responses of
human lung cells exposed to any type of MNs via the gas phase
(Oostingh et al., 2013, Kohl et al., 2011).
NanoMILE developed in vitro methods for high throughput screen-
ing of (eco)toxicity across a broad range of endpoints and species in
order to identify mechanisms of toxicological action. In this context
NanoMILE focused on developing tools for analysis of MNs interactions
with environmental and biological macromolecules (e.g. proteins,
lipids, sugars, nucleic acids) before and after uptake and localisation in
cells. The project also developed tools to establish the nature and trans-
formations of theMNs coronas under realistic environmental conditions
(Madani et al., 2012).
EURO-NANOTOX researchers developed in vitromethods to investi-
gate the kinetic behaviour (e.g. transport across barriers, tissue distribu-
tion, elimination) of various MNs (Mrakovcic et al., 2013, Mrakovcic et
al., 2014). The project focussed on assessment of cellular particle uptake
and evaluation of acute cellular effects. More speciﬁcally, the effects on
speciﬁc organelles (lysosomes) are being studied. Particle uptake and
cytotoxicity are assessed in physiologically relevant scenarios (e.g. co-
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In order to perform these analyses, the project partners have developed
cell cultures and various assayswithmicroscopic and photometric/ﬂuo-
rometric/luminescent readout. These assays detect speciﬁc cellular
changes due to the effects ofMNs andprovide results suitable to identify
the underlying mechanisms of toxicological action (e.g. Ca-signalling,
radical generation, decrease of lysosomal function).3.2.3.2. In silico tools. The development of multiple similar, but not iden-
tical nanoforms by the nanotechnology industry poses an immediate
problem for RA, as many of them remain untested for various reasons,
one of which is the cost. To use the existing knowledge as efﬁciently
as possible the development of Intelligent Testing Strategies for MNs
was recommended (Stone et al., 2013). Such ITSwould combine testing
and non-testingmethods to generate data for RA. In this context the de-
velopment and application of in silico tools has become prominent and
a number of such tools have been proposed (Burello andWorth, 2011a,
Burello andWorth, 2011b, Puzyn et al., 2011, Puzyn et al., 2009a, KAR et
al., 2014, Richarz et al., 2015, Toropova and Toropov, 2015, Labowsky et
al.). Statistical analysis and machine learning methods (e.g. principal
component analysis, neural networks) have also been applied to
model the properties and effects of MNs (Puzyn et al., 2009b, Puzyn et
al., 2009a, Toropov et al., 2007, Toropov and Leszczynski, 2006, Sayes
et al., 2013, Lynch et al., 2014). Such methods were used for example
in the EU-funded MODERN project with the aim to establish in silico
modelling of the effects of metal and metal oxide MNs (Liu et al.,
2013b, Liu et al., 2014, Liu et al., 2013a, Gómez et al., 2013).3.2.4. Risk assessment models
Some high-tier quantitative models have been developed for both
environmental and human health RA. These tools require a certain
level of expertise to apply and are therefore not user-friendly from
the point of view of non-experts. The only such tool capable of
performing uncertainty analysis is the Species Sensitivity Distribution
(SSD) approach proposed by Gottschalk et al. (2013), which uses a
Monte Carlo probabilistic approach to generate SSD that are then com-
pared with probability distributions of PECs for estimation of environ-
mental risks. Semenzin et al. (2015) developed a Species Sensitivity
Weighted Distribution (SSWD) methodology, which similarly esti-
mates SSD. Its distinguishing feature is that it combines species rele-
vance and trophic level abundance criteria to evaluate reliability of
ecotoxicological data and their relevance for ecological RA (Semenzin
et al., 2015).
NanoSafer 2 is a quantitative model that uses data onmaterial prop-
erties, processes and production facilities to assess occupational risk. A
key new development as compared to the former version of the tool is
its capability to estimate exposure from spray processes. In addition, it
can perform nano-speciﬁc hazard assessment based on read-across be-
tween MNs on the basis of material properties and hazard indicators.
The results of this assessment can then be tested against in vivo exper-
iments. The tool uses theRisk Quotient (i.e. the ratio of an exposure dose
to a human effect threshold) to estimate risk.
The EU-funded GUIDENANO project is developing another quantita-
tive web-based RA tool covering the hotspots of exposure and hazard
important for human and environmental health during the entire life
cycle of nano-enabled products. One of the distinguishing features of
the tool includes the description of the MNs form in all its life cycle
stages.
The NanoSafer 2 and GUIDEnano tools still have no documented ap-
plications, while themodels byGottschalk et al. (2013) and Semenzin et
al. (2015)were tested in real case studies, including pristine TiO2 aswell
as Ag, Zn, CNTs and fullerenes released from consumer products in sur-
face waters, sewage treatment plant efﬂuents, soils and sludge-treated
soils.3.2.5. Physicochemical characterization tools
In order to identify if a pristine (as produced) substance is a
nanomaterial one can use the European Commission's or sector-speciﬁc
regulatory deﬁnitions (e.g. the ones for cosmetics or food), which are
mainly based on size distribution and volume speciﬁc surface area.
However, pristine MNs undergo transformation reactions during incor-
poration into products and when released from them. The releasedma-
terials age under various environmental conditions. Thus, at each
lifecycle stage there is a potential of exposure to MNs with different
physicochemical properties (Hristozov et al., 2014, Oomen et al.,
2014b, Arts et al., 2015b). A portfolio of physicochemical characteriza-
tion techniques is required to understand the identity of the MNs
reaching target organs and environmental species. It is essential that
these tools are validated and reproducible across laboratories.
A number of efforts are currently underway both on the European
and international levels to develop such tools for MNs. Some key initia-
tives are the EU-funded projects NANOVALID, MARINA, NANODEFINE,
SUN, NANOLYSE, and NANOREG, which work in close collaboration to
develop and test protocols for sample preparation and physicochemical
characterization of both pristine MNs and such released from products
into the environment.
NANOVALID developed validated protocols for measuring MNs and
controlling their dispersion stability by means of novel labeling
methods. The project developed new approaches to increase precision
and reproducibility of tools for detection of low MNs concentrations in
(complex) biological and environmental samples. This includes,
among others, advanced secondary electron and optical imaging and
spectroscopic techniques for analysis of chemical composition, size
and morphology. Similarly, NanoDeﬁne developed sampling strategies,
dispersion and characterization protocols for MNs able to distinguish
between large primary constituent particles and non-dispersible aggre-
gates. The project identiﬁed and improved rapid screening methods
such as Nanoparticle Tracking Analysis (NTA), Centrifugal Liquid Sedi-
mentation (CLS), and ICP-MS.
The SUN project focused on developing methods for the characteri-
zation of MNs released from products and aged in the environment.
Some examples are the following: i) single particle ICPMSwith reaction
cell technology for detection of nanoscale Fe2O3 and CuO; ii) combina-
tion of AF4 and ICPMS for detection of nanoscale SiO2 in food; iii) proto-
cols for release of Fe2O3 from plastics and SiO2 from food; iv) climate
chamber weathering protocols for: a) Fe2O3 in plastics, and b) CuO
painted on wood; v) wet weathering protocols for Fe2O3 and organic
pigments in plastics; vi) a protocol for studying the release of MWCNT
from polymers (based on isotopic labeling—14C-CNTs); vii) protocols
for studying the release of MNs from waste during incineration,
recycling and landﬁlling.
NANOREG theoretically evaluated a number of OECD TGwith a view
to improve and validate them forMNs and also identiﬁed SOPs forwater
solubility and dispersion stability testing. The procedures include ele-
mental analysis with ICP-MS and FFF and are applicable to in vitro cell
culture and ecotoxicity dispersion media, where direct measurement
by DLS may be hindered due to the presence of heterogeneous organic
material (e.g. cells, exudates, proteins) in the medium.
In addition to developingmethods for sample preparation and char-
acterization of pristine and weathered MNs for (eco)toxicological eval-
uation and fate experiments, there is a pressing need for analytical
methods that allow the routine detection of MNs in food. Researchers
from the NANOLYSE project addressed this need by developing sample
preparation methods, rapid imaging, screening and analytical protocols
for the identiﬁcation, characterization and quantiﬁcation of inorganic
and organic nanoparticles in the matrix of food products. These
protocols are based on various techniques such as Electron microscopy,
Surface Plasmon Resonance biosensor, Immunoassays (ELISA),Multide-
tector Field Flow Fractionation (FFF-UV/LS/ICP-MS), single particle ICP-
MS, Hydrodynamic Chromatography, andDifferentialMobility Analysis.
These methods were developed for food/beverage matrices, but can be
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3.2.6. Decision analytical tools
Decision analytical methods (e.g. Bayesian inference, weight of evi-
dence, MCDA) are useful for identifying, clearly representing, and for-
mally assessing aspects of decision making in order to recommend
courses of action (Clemen and Reilly, 2013). Some of these methods
are used in Decision Support Systems (DSS), which refer to a wide
range of computer-based tools consisting of databases, computational
models and user-friendly interfaces.
Subramanian et al. (2015) reviewed the state of the art in the area of
decision analytical tools applicable to assess trade-offs among MNs
risks, costs, and beneﬁts. One of these tools is the LICARA NanoScan,
which determines and weighs beneﬁts versus risks over the lifecycle
of MNs-based products (Van Harmelen et al., 2016). This low-tier tool
is speciﬁcally intended for SMEs to help them identify sources of poten-
tial risks from their products so that they can take timely preventive ac-
tions. It uses principles and assessment criteria from the Precautionary
Matrix, NanoRiskCat and Stoffenmanager Nano, and integrates them
with expert judgement through MCDA. LICARA NanoScan is available
as an online tool and will be integrated as the lower tier of the DSS cur-
rently developed in the SUN project. The higher tier of the SUNDSS will
include a risk control module performing quantitative occupational,
consumer and environmental RA. If the risks are not acceptable the
tool will propose suitable RMM. In addition, it will perform Socioeco-
nomic Analysis (SEA) to check if the beneﬁts of using certain
nanoproducts signiﬁcantly outweigh their risks.
4. Discussion and conclusions
In order to assess the strengths and limitations of the existing frame-
works and tools for RA ofMNswe adopted amulti-perspectivemethod-
ology that combined a classical review of peer-reviewed papers with an
analysis of grey literature and a survey to collect information from on-
going and completed nanoEHS research projects. We deem that this
methodology was successful in collecting most information needed for
our critical appraisal of the existing nanoEHS toolbox. Nevertheless,
we encountered some issues, especially in conducting the survey, as
the involved respondents often reported several tools in a single re-
sponse, which made it difﬁcult to evaluate them individually. This
issue was particularly strong in the case of experimental protocols
where the responders tended to report types of methods instead of sin-
gle protocols. This phenomenon introduced ambiguity and likely errors
in the assessment, which were impossible to avoid.
Based on our analysis,we conclude that none of the reviewed frame-
works were able to fulﬁll all evaluation criteria. Therefore, we recom-
mend the development of a comprehensive framework for RA of MNs
that integrates all strengths listed in Table 3. Such a framework is need-
ed for example to inform regulatory guidance. There has been a lot of
discussion on possible adaptations of the REACH CSA for MNs and
both industry and regulators need guidance on how to properly imple-
ment the CSA. The framework should represent an integrated (human
health and environmental) strategy covering all stages of the lifecycles
of nano-enabled products and should be able to address the needs of
the different stakeholders (e.g. industries, regulatory agencies, insur-
ance companies) involved in nanotechnology innovation supply chains.
Moreover, the framework should beﬂexible enough to address different
assessment goals depending on user needs, and should consider all data
already available as starting point in order to select the most appropri-
ate tools to ﬁll the data gaps.
In generating data for hazard and exposure assessment the frame-
work should take into consideration a number of nano-speciﬁc aspects,
some of which recommended by OECD: i) sufﬁcient data on the physi-
cochemical properties of theMNs should be generated, including infor-
mation on surface properties and interactions; ii) the effects of testmethods and the exposure matrix on the testing outcomes and on
inter-comparability of the data used in the assessment should be evalu-
ated; iii) the complex nature of the material (e.g. variation in size, sur-
face properties, and composition) that create a heterogeneous range
of particle types should be considered, and iv) the interactions of the
MNs in exposure and toxicity contexts should be taken into account.
The framework should selectively incorporate the existing tools for
RA of MNs. There is an impressive number of such modelling tools
and although they are intended to serve similar purposes (e.g. exposure,
fate, hazard or risk assessment) their speciﬁcations (input data require-
ments, output formats, and application domains) vary considerably,
which makes their integration in a consistent framework challenging.
Most of the existing modelling tools are screening-level procedures to
identify sources of human health risk in the lifecycle of MNs and to pin-
point areas of knowledge deﬁcits. There is a pronounced need for quan-
titative tools that can effectively address the existing uncertainties in
order to allow regulatory RA of MNs. Such tools have been developed
inmajor projects, butmost of themhave not been calibrated and/or val-
idated due to paucity of relevant experimental data. Therefore, several
years may pass before they can be applied with conﬁdence, while risk
assessment results are needed in the near term to inform robust risk
management decision making. The application of decision analytical
methods (Subramanian et al., 2015) may be useful in addressing this
need. Such tools can potentially overcome some of the limitations of
the existing qualitative approaches, while at the same time contribute
to a ﬂexible framework for RA ofMNs, adaptable to various needs. In ad-
dition, they can help the insurance sector develop risk transfer practices
for nanotechnologies. This is indeed a pressing need as the current lack
of practices (e.g. captives, self-insurance, risk sharing) to disperse risk
through access to insurance markets may cause loss of investments in
product development, which would affect the entire nanotechnology
industry.
In order to facilitate regulatory RA of MNs in the medium-long term
it is important to perform sensitivity testing analysis, performance test-
ing, calibration and ﬁnal demonstration of the different exposure, haz-
ard, and risk modelling tools. Such sensitivity testing could use
statistical methods to analyse the outputs from speciﬁc tools as function
of their inputs. Tailored sensitivity and performance test paradigms
should be established considering the types of tools and input data.
The sensitivity analysis could involve screening analysis to rank the rel-
ative order of weight of each input, which can be followed by local and
global sensitivity testing using the one-factor-at-a-time approach to as-
sess the contribution of each input to the overall uncertainty in the as-
sessment results.
In this way the sensitivity analysis can establish ranges of uncertain-
ty as function of the different model inputs. This can facilitate the quan-
titative performance testing of the tools' predictability. The performance
tests should be detailed enough to capture speciﬁc capabilities of the
tools, such as the ability to perform exposure assessment of speciﬁc
product groups. The outcome of the performance tests would be an
analysis of the suitability, data availability, sensitivity, and observed un-
certainty in the tests against the test data, aswell as identiﬁcation of fur-
ther model development needs.
The results of the model analyses can inform experimental designs
ormonitoring practices to generate sufﬁcient data for performance test-
ing and validation. This iterative process would ideally lead to improv-
ing analytical/experimental protocols and tailoring them to the data
needs of the modellers. It can be anticipated that these needs would
cover physicochemical material or product characteristics, measured
or estimated release or emission potentials, description of the exposure
scenarios with contextual information, measured human exposure/en-
vironmental concentrations, test data from in vitro and in vivo (eco)tox-
icological studies.
Until now, the models discussed in this paper, at best, have only
been demonstrated and not thoroughly tested and calibrated. Often,
the model developers end up with the realization that existing data
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mation and conditions, which are required to truly calibrate and assess
a models' performance. This has led to the generation of a considerable
amount of empirical data onworkplace and consumer exposure, includ-
ing data on emission characteristics and source strengths from different
release scenarios in the production and use stages, such as synthesis,
powder handling, simulated sanding, drilling and cutting of nanocom-
posites, landﬁlling and incineration. Moreover, lots of data on physico-
chemical characteristics and (eco)toxicology of MNs have been
generated. However, currently there are few reliable data for calibration
and validation of the existing fate, transport and exposure models. One
important reason for this is that the available sampling and measure-
ment tools need further improvements before they could conﬁdently
distinguish MNs from background particles, which calls for more re-
search on increasing their sensitivity and selectivity. Moreover, data
are lacking on key processes determining the environmental fate and
behaviour of MNs (e.g. aggregation, agglomeration, dissolution, resus-
pension), which have only recently been considered in the nano-specif-
ic environmental fate and exposure models. These processes depend
not only on the characteristics of theMNs but also on themedia embed-
ding them, which complicates their monitoring. In aquatic systems, im-
portant processes affecting the transport, transformation and
bioaccumulation of MNs include aggregation and disaggregation, disso-
lution, precipitation, diffusion, advection, and sedimentation.MNs char-
acteristics such as surface afﬁnity are the driving forces for dissolution
and biotransformation processes as well as for the complex interactions
with abiotic and biological surfaces. It is important to understand how
these characteristics can be linked to the nano-speciﬁc models de-
scribed above as well as to certain partitioning and bioavailability
models established for conventional chemicals. To achieve this more
data and mechanistic knowledge need to be generated. In order to gen-
erate these data, it is important to develop experimental techniques for
investigating the agglomeration/aggregation kinetics of MNs in the
aquatic, soil and sediment compartments with the speciﬁc goal of pro-
viding attachment efﬁciency factors for quantifying the association of
MNs with suspended ambient solids and the removal of MNs from the
water column to the sediment. This should involve the design of dedi-
cated experimental protocols to deﬁne agglomeration/aggregation
kinetics of selected MNs that are key in interpreting environmental
fate and transport in realistic environments. Special attention should
be given to experimental designs able to study how the MNs surface
coating/functionalization inﬂuence their aggregation/agglomeration
and sedimentation kinetics. These activities should be designed consid-
ering both MNs physicochemical properties (e.g. surface coating/
functionalization, dimension, surface charge, shape) and environmental
parameters (e.g. temperature, salinity, organic carbon content), and
should be directed especially towards addressing hetero-agglomera-
tion/aggregation and sedimentation processes.
Moreover, future research should investigate dissolution kinetics as
someMNs could dissolve rapidly into ions. This should involve dynamic
testing approaches determining dissolution in a system where it hap-
pens towards an inﬁnite sink, so that the rate is not changed due to
back-reactions, which could occur in static systems, where dissolved
ions build up in the medium during the dissolution process. This
would better reﬂect the behaviour of MNs in the soil, where in a static
test most of the produced ions would be quickly adsorbed to soil com-
ponents, which would reduce the ion activity in the pore waters, and
would accelerate the dissolution.
There have been considerable efforts to develop validated physico-
chemical characterization, environmental measurement, in vitro and
in vivo testing protocols and to ensure that they generate data repro-
ducible across laboratories. Nevertheless, the majority of these data
and tools are currently scattered across project documentation and are
difﬁcult or impossible to access.Moreover,most of thedata are recorded
as large volumes of unstructured text (e.g. technical reports, journal ar-
ticles), which makes it difﬁcult to automate the process of informationextraction and analysis. The data sources are also physically separate,
forcing researchers to spend considerable time locating them. The
existing database services use different interfaces, data formats and ter-
minologies. These issues have created the pressing need to advance the
current efforts on developing databases and tools towards developing
an infrastructure to support a network of data and analytical services
for nanoEHS research that share standard formats and a common ontol-
ogy. This infrastructure should be open and accessible so that the avail-
able resources can be used freely for RA.
Using this infrastructure to access large sets of comparable physico-
chemical, hazard, release and exposure data could boost the develop-
ment of computational in silico models and could facilitate in vitro-in
vivo extrapolations. Such developments could eventually enable risk as-
sessors to use the huge volume of existing in vitro data for RA of MNs,
which would signiﬁcantly reduce testing costs and the use of experi-
mental animals. The analysis of these data bymeans of relevant statisti-
cal andmachine learning techniques could help to develop strategies for
grouping of MNs based on certain physicochemical, release, exposure,
biokinetic and/or biological/toxicological attributes. Grouping can facil-
itate the risk assessment process through waiving of testing, or to high-
light issues that need additional analysis. It could enable read-across
among nanoforms and non-nanoforms, and could inform safer product
design.
Grouping and read-across approaches are well-established for
chemical substances, but a number of challenges prevent their success-
ful implementation for MNs, including: i) the fact that many physico-
chemical and structural properties of pristine NMs are inter-related
and thus cannot be analysed in isolation from others (e.g. increasing
surface charge may impact on hydrophobicity, or changing the shape
of a NMmay introduce defects or alter the atomic conﬁguration of the
surface); ii) the ageing, transformation and coating of NMs by biomole-
cules in environmental or biological media may affect their interactions
with organisms and cells, and thus modify their toxicity. Overcoming
these challenges requires a profound understanding of which (combi-
nations of) the intrinsic and extrinsic structural and physicochemical
characteristics of MNs dispersed in environmental or biological media
or embedded in product matrices affect their release potential, uptake,
biokinetic behaviour, toxicological modes of action or adverse outcome
pathways. In order to develop such understanding it is useful to gener-
ate data on the intrinsic and extrinsic properties derived from existing
physicochemical analyses of pristine, released, aged and modiﬁed MNs
in different biological and environmental media as well as the observed
adverse effects based on (eco)toxicological studies.
There are differences in the perspectives of the existing grouping
frameworks in terms of the hierarchy of relevant properties, but those
are not contradictions. Instead they call for an integration in a consis-
tent, multi-perspective strategy in order to i) help industries and regu-
lators assess the environmental and human health risks of MNs in cost
effective manner, and to ii) inform safer by design practices in the
early stages of product development. In order to achieve the ﬁrst, the
framework should guide the user through the selection of established
experimental and modelling approaches to generate the data needed
for the identiﬁcation and classiﬁcation of NM according to regulatory
deﬁnitions, and to enable predictive in silico modelling. In order to
achieve the latter, the framework could be based on the StageGate con-
cept so that the results of its application are fed directly into innovation
supply chains. In order to increase the attractiveness of the framework
for SMEs and industries, it would be useful to develop it into a user-
friendly web-based decision support tool.
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